01969nam a2200289   4500001000800000005001700008007000300025008004100028040000800069041000800077100003500085245008400120300002300204520098900227650004601216650002001262650004601282650004201328650003501370700003001405700002901435700002801464700002901492773011001521942003101631999001701662ESSALUD20260817163214.0ta      t        pe ||||| |||| 00| 0 spa d  aBMG  aeng  aShelley, Donna  eAutor954129  aEvidence-based tobacco-cessation strategies for low-and middle-income countries  apáginas: 684-693  aTobacco use is the leading cause of preventable death globally, claiming more than 7 million lives each year. The burden of disease is highest in low- and middle-income countries, where more than 80% of the world’s 1.3 billion tobacco users reside. The World Health Organization (WHO) defines six proven strategies to reduce tobacco use, referred to by the acronym MPOWER, with one of the strategies being to offer tobacco users help with quitting. Many low- and middle-income countries provide tobacco-cessation services; however, only 31 meet the WHO best practice, defined as providing both cost-covered behavioral interventions and pharmacotherapy. In this article, case studies from India and Vietnam illustrate how cross-country differences in tobacco-related sociocultural norms, tobacco-use patterns (e.g., smokeless tobacco or water pipes), the tobacco-control regulatory environment, industry influence, and health care system financing shape treatment access and uptake.   aPRESTACIONES DE SERVICIOS DE SALUD954130  aADICCION953681  aPOLÍTICA SANITARIA INTERNACIONAL954131  aMEDICINA CLÍNICA AMBULATORIA953762  aSALUD PÚBLICA GENERAL954132  aRigotti, Nancy A. 954133  aMurthy, Pratima  954134  aVan Minh, Hoang 954135  aSiddiqi, Kamran  9541360 022717922647dMassachusetts NEJM GroupoNEJM010tThe New England Journal of Medicine wESSALUDx0028-4793  cARTICULOSe2026-08-17zSQB  c22828d22828